Difference between revisions of "Cinchocaine"

From Self-sufficiency
Jump to: navigation, search
m (Citations: [Pu184]Misc citation tidying. You can use this bot yourself. Report bugs here.)
 
m (1 revision)
 
(No difference)

Latest revision as of 15:47, 19 September 2010

Cinchocaine
File:Cinchocaine.svg
Systematic (IUPAC) name
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
Clinical data
Routes of
administration
topical, intravenous (equine euthanasia)
Identifiers
CAS Number 85-79-0
ATC code C05AD04 (WHO) D04AB02 N01BB06 S01HA06
PubChem CID 3025
DrugBank APRD00915
ChemSpider 2917
Chemical data
Formula C20H29N3O2
Molar mass 343.463 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Cinchocaine (or Dibucaine) is an amide local anesthetic. It is the active ingredient in some topical hemorrhoid creams such as Proctosedyl. It is sold under the brand names Cincain, Nupercainal, Nupercaine and Sovcaine [1].

Dibucaine is insoluble in alkaline aquatic environments.

It is also a component of the veterinary drug Somulose, used for euthanasia of horses and cattle.

External links

  • Abdel-Ghani N, Youssef A, Awady M (2005). "Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry". Farmaco. 60 (5): 419–24. doi:10.1016/j.farmac.2005.03.001. PMID 15910814. 
  • Souto-Padron T, Lima AP, de Oliveira Ribeiro R. (2006). "Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi". Parasitol Res. 99 (4): 317. doi:10.1007/s00436-006-0192-1. PMID 16612626. 
  • Nounou M, El-Khordagui L, Khalafallah N (2005). "Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles". Acta Pol Pharm. 62 (5): 369–79. PMID 16459486. 
  • Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.



de:Dibucain

it:Cincocaina pt:Dibucaína